Volume 79, Pages S3-S8 (April 2011)

Slides:



Advertisements
Similar presentations
Volume 68, Pages S24-S28 (July 2005)
Advertisements

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Modification of the trade-off hypothesis of Slatopolsky and Bricker as it relates to the adaptation of the body to decreased functional renal mass in an.
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Pages S1-S7 (June 2005)
High Prevalence of Vitamin D Inadequacy and Implications for Health
CKD–Mineral and Bone Disorder: Core Curriculum 2011
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Electrolyte Disorders Associated With Cancer
Volume 73, Issue 1, Pages 3-5 (January 2008)
Fibroblast Growth Factor 23 and CKD Prognosis
High Prevalence of Vitamin D Inadequacy and Implications for Health
CKD–Mineral and Bone Disorder: Core Curriculum 2011
Phosphorus: Another Devil in Our Diet?
Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease  Adriana S. Dusso,
FGF23 or PTH: which comes first in CKD ?
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Volume 78, Pages S10-S21 (August 2010)
Figure 4 Model of changes in the serum levels
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 78, Issue 10, Pages (November 2010)
FGF23–parathyroid interaction: implications in chronic kidney disease
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Volume 79, Pages S24-S27 (April 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 79, Pages S3-S8 (April 2011)
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Chapter 3: Management of progression and complications of CKD
Overview of the 2017 KDIGO CKD-MBD Update: Practice Implications for Adult Hemodialysis Patients  Judith Beto, PhD, RDN, FAND, Nisha Bhatt, MD, Teresa.
Volume 60, Issue 6, Pages (December 2001)
Volume 76, Pages S50-S99 (August 2009)
Tally Naveh-Many, Justin Silver  Kidney International 
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Volume 79, Pages S20-S23 (April 2011)
Volume 66, Pages S25-S32 (September 2004)
Hyperphosphatemia of chronic kidney disease
Use of vitamin D in chronic kidney disease patients
Florian Lang, Michael Föller  Kidney International 
Clinical relevance of FGF-23 in chronic kidney disease
Volume 67, Pages S33-S36 (June 2005)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 69, Issue 3, Pages (February 2006)
Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism 
Volume 68, Pages S24-S28 (July 2005)
Role of vitamin D receptor activators on cardiovascular risk
Evidence and Outcomes in CKD
Volume 87, Issue 3, Pages (March 2015)
Volume 75, Issue 9, Pages (May 2009)
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics  William G. Goodman, L.D. Quarles 
Fibroblast growth factor 23: the making of a hormone
Phosphate and the parathyroid
Volume 56, Issue 3, Pages (September 1999)
Latest findings in phosphate homeostasis
Volume 71, Issue 8, Pages (April 2007)
Volume 78, Issue 10, Pages (November 2010)
Volume 80, Issue 10, Pages (November 2011)
Increased parathyroid expression of klotho in uremic rats
Recent developments in the management of secondary hyperparathyroidism
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
The ins and outs of phosphate homeostasis
Diagram of the mechanisms involved in limiting the ability of the kidney to maintain the levels of 1,25-dihydroxyvitamin D in chronic kidney disease (CKD).
Control of uremic bone disease: Role of vitamin D analogs
Volume 61, Issue 4, Pages (April 2002)
Marta Christov, Harald Jüppner  Kidney International 
Volume 83, Issue 1, Pages (January 2013)
Tamara Isakova, Orlando M. Gutiérrez, Myles Wolf  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop. Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop.
Volume 64, Pages S131-S136 (November 2003)
Presentation transcript:

Volume 79, Pages S3-S8 (April 2011) The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder  Eduardo Slatopolsky  Kidney International  Volume 79, Pages S3-S8 (April 2011) DOI: 10.1038/ki.2011.23 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Hypothetical treatment of sodium excretion in chronic kidney disease (see text for details). GFR, glomerular filtration rate; FENa, fractional excretion of sodium; FLNa, filtered load of sodium. Figure newly constructed from data in Bricker et al.2 and Bricker.3 Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Urinary sodium excretion in patients with advanced chronic kidney disease (stages 4–5). All patients with glomerular filtration rates ranging from 25 to 2.6ml/min maintain perfect Na balance after ingestion of 60 or 120 mEq of Na/day. Reproduced by permission from Slatopolsky et al.4 Copyright 1968 by the American Society for Clinical Investigation. Reproduced with permission from the American Society for Clinical Investigation in the format Journal via Copyright Clearance Center. Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Comparison of tubular reabsorption of phosphate (TRP) and glomerular filtration rate (GFR) in a group of normal subjects and 24 patients with different degrees of chronic kidney disease. The lower the GFR, the lower the TRP or the greater the excretion of phosphate per nephron. Reproduced by permission from Slatopolsky et al.6 Copyright 1968 by the American Society for Clinical Investigation. Reproduced with permission from the American Society for Clinical Investigation in the format Journal via Copyright Clearance Center. Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Effects of a low-phosphate, low-calcium diet on serum calcium, calcitriol, phosphorus, and parathyroid hormone (PTH) in dogs with chronic kidney disease and established secondary hyperparathyroidism. *p<0.05. Figure newly constructed from data in Lopez-Hilker et al.11 Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 The effects of phosphorus in the culture media on the secretion of parathyroid hormone (PTH) in a normal rat parathyroid gland in vitro. In the two experimental conditions, the concentrations of ionized calcium and 1,25(OH)2D3 were identical. Error bars denote standard error. Adapted with permission from Slatopolsky et al.13 Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 6 Summary of the factors involved in the pathogenesis of secondary hyperparathyroidism. A decrease in ionizing calcium (ICa) is crucial in the development of secondary hyperparathyroidism. This change in ICa is secondary to phosphate retention and to low levels of 1,25(OH)2D3. Phosphate retention increases fibroblast growth factor (FGF)-23, which, in conjunction with its cofactor, the Klotho protein, decreases the activity of the 1α-hydroxylase and increases the 24α-hydroxylase, thus decreasing the levels of circulating 1,25(OH)2D3. In addition, phosphate retention, independent of change in ICa, posttranscriptionally increases the synthesis of parathyroid hormone (PTH). The 1,25(OH)2D3, independent of calcium, suppresses the transcription of the PTH gene. Decreases in the vitamin D receptor, calcium sensor receptor, and Klotho–FGFR1 receptor complex in the parathyroid gland also aggravate the development of secondary hyperparathyroidism. Kidney International 2011 79, S3-S8DOI: (10.1038/ki.2011.23) Copyright © 2011 International Society of Nephrology Terms and Conditions